BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

REGiMMUNE 

3-12-5 Shibaura, Ishizaka
Building 6F
Minato-ku  Tokyo  108-0023  Japan
Phone: 81-3-3456-0820 Fax:


SEARCH JOBS




Industry
Biotechnology






 Company News
REGiMMUNE To Present Its Method For Long-Term Tolerance In Organ Transplantation At World Transplant Congress In San Francisco 7/28/2014 10:16:32 AM
REGiMMUNE Nabs $9.2 Million Series D Financing 2/14/2014 7:35:05 AM
REGiMMUNE Begins Enrollment For Phase II Clinical Trial For Graft Versus Host Disease 2/6/2014 9:34:01 AM
REGiMMUNE Initiates Phase I/II Clinical Trial for GvHD 2/1/2012 8:40:05 AM
REGiMMUNE Presents New ToleroVax Data at the 2010 American Transplant Congress 5/5/2010 11:19:23 AM
REGiMMUNE to Present Data From Preclinical Study of RGI-2001 at the 2010 American Transplant Congress 4/28/2010 11:26:50 AM
Astellas Pharma Inc. and REGiMMUNE to Collaborate on New Vaccine Technology 7/22/2009 10:34:51 AM
REGiMMUNE Presents Enhanced Efficacy Data in Preclinical Transplantation Models at the 2009 American Transplant Congress 6/1/2009 11:12:47 AM
REGiMMUNE to Present at the 2009 American Transplant Congress 5/12/2009 11:36:38 AM
REGiMMUNE Receives $12 Million in Grants to Develop Transplant and Allergy Drugs 12/8/2008 11:59:24 AM
12